ADCTVSBTAI• 3 Months (Normalized)
ADCT vs BTAI (ADC Therapeutics SA vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ADCT Performance $1.23
+7.89%
ADC Therapeutics SA
Normalized Baseline0.00%
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ADCT LEADS
+7.89 pts
ADCT outperforming by 7.89 percentage points
ADCTBTAI
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ADCT BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | ADCT Price | ADCT Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.23 | +7.89% | $- | - | |
| Sep 28, 2026 | $1.26 | +10.53% | $- | - | |
| Sep 25, 2026 | $1.27 | +11.40% | $- | - | |
| Sep 24, 2026 | $1.29 | +13.16% | $0.04 | -97.42% | +110.58% |
| Sep 23, 2026 | $1.31 | +14.91% | $0.05 | -96.72% | +111.63% |
| Sep 22, 2026 | $1.23 | +7.89% | $0.04 | -96.74% | +104.63% |
| Sep 21, 2026 | $1.12 | -1.75% | $0.06 | -95.51% | +93.76% |
| Sep 18, 2026 | $1.05 | -7.89% | $0.06 | -95.77% | +87.88% |
| Sep 17, 2026 | $1.06 | -7.02% | $0.08 | -94.52% | +87.50% |
| Sep 16, 2026 | $1.05 | -7.89% | $0.07 | -95.12% | +87.23% |
| Sep 15, 2026 | $1.09 | -4.39% | $0.04 | -96.74% | +92.35% |
| Sep 14, 2026 | $1.11 | -2.63% | $0.05 | -96.71% | +94.08% |
| Sep 11, 2026 | $1.07 | -6.14% | $0.05 | -96.28% | +90.14% |
| Sep 10, 2026 | $1.11 | -2.63% | $0.05 | -96.35% | +93.72% |
| Sep 09, 2026 | $1.22 | +7.02% | $0.05 | -96.57% | +103.59% |
Page 1 of 5